fda remove semaglutide from shortage list Proposes Ban on Bulk Compounding for Semaglutide, Tirzepatide, and Liraglutide Hims & Hers stock falls

Track GLP-1 prescribing trends with all-payer claims data As research into GLP-1s continue to expand the indications for this therapy, payer and employer coverage policies will keep evolving alongside patient behavior

You can find additional and more specialized prior authorization forms on the Express Scripts website at www.express-scripts.com/pa

Clinical Reviewer Pharmacy prescriber Craig is based in the UK and regularly reviews our content to ensure clinical accuracy

Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden

We will be covering the committee sessions as they happen